Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Receivables - Net (2025 - 2026)

Updated

Crinetics Pharmaceuticals' Receivables - Net was $11.96 million in Q2 2026, up 110.4% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Receivables - Net (2025 - 2026) Analysis & Trends

At the end of FY2025, Receivables - Net at Crinetics Pharmaceuticals came in at $592,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.96 Mn
Mar 31, 2026 5.68 Mn
Dec 31, 2025 592,000.00
API Access

Crinetics Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CRNX&period=max&api_key=YOUR_API_KEY